The effect of 10% pegagan (centella asiatica (L.) urban) extract cream on melanin amount in the guinea pig skin vitiligo model
Keywords:
Centella extract, Melanin, HydroquinoneAbstract
AbstractPegagan is one of the plants used by the community for medicinal purposes; it contains a variety of compounds, including the following: Pegagan contains antioxidant and anti-inflammatory effects. The in vivo effects of repigmenting chemicals generated from centella asiatica extract have not been explored prior to this study.The objective is to demonstrate that 10% pegagan extract cream affects melanin levels in guinea pig models of vitiligo.Subjects and MethodsThis is a strictly experimental study with a post-test-only control group design involving the administration of 10% centella asiatica extract cream. In this study, 16 male guinea pigs were divided into two groups. Both groups of guinea pigs had cream containing hydroquinone administered to their backs daily for eight days. The control group then did not get any treatment. The treatment group received a 10% Pegagan extract lotion for fourteen days. Histopathological examination of tissue stained with Masson-Fontaine. The amount of melanin is based on the ratio of pixels in the melanin area to the total number of pixels in the epidermal tissue.ResultsThe group that got 10% Pegagan extract cream had the highest concentration of melanin, and the difference was statistically significant (p0.05). ConclusionThe conclusion of this study is that 10% centella asiatica extract cream improves the level of melanin in the skin of guinea pigs with a vitiligo model.Keywords: centella extract, melanin, and hydroquinoneReferences
Ezzedin K and Harris JE. Vitiligo. In: Kang S, Amagai M, Bruckner AL, Enk 35 AH, Margolis DJ, McMichael AJ, Orringer JS, editors. Fitzpatrick Dermatology. Ed 9th. New York: McGraw Hill. 2019:1330-50
Kruger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children/adolescents and adults. Int J Dermatol. 2012 Oct;51(10):1206-12
Rizal Y, Lestari S. Insidensi vitiligo di poliklinik kulit dan kelamin RSUP Dr. M Djamil Padang tahun 2001-2006. MDVI. 2008; Januari 35 (1): 77.
Sandoval M. Immunopathogenesis of vitiligo. Autoimmun Rev. 2011 Oct;10(12):762–5.
Sravani PV. Determination of oxidative stress in vitiligo by measuring superoxide dismutase and catalase levels in vitiliginous and non-vitiliginous skin. Indian J Dermatol Venereol Leprol Dermatol. 2009;75:268-71.
12Olasade OA. Dermatology Psychosocial problems in patients with vitiligo in Nigeria. Sudan J Dermatol. 2007;5:51-8
Kruger C, Schallreuter KU. Cumulative life course impairment in vitiligo. Curr Probl Dermatol. 2013;44:102–17
Parsad D, Pandhi R, Dogra S, Kanwar AJ, Kumar B. Dermatology Life Quality Index score in vitiligo and its impact on the treatment outcome. Br J Dermatol. 2003;148:373-4
Suman B, Pranjal D, Rakesh M. Assessment of Quality of Life in Vitiligo patients attending a tertiary care hospital – a cross sectional study. Ind Psychiatry Journal. 2021;30(1):62-66
Asri E, Kampar P. Hubungan Vitiligo Area Scoring Index (VASI) dengan Dermatology Life Question Index (DLQI) pada pasien vitiligo di RSUP.Dr.M.Djamil Padang Periode 2015-2016. Jurnal Kesehatan Andalas. Vol 8 (3) 2019;1-5
Nurina DR, Rahmadewi R. Studi Retrospektif: Profil pasien baru vitiligo. Periodical of Dermatology and Venereology.2022;28(2):130-6
Yaghoobi R, Omidian M, Bagherani N. Vitiligo: A review of the published work. Journal of Dermatology. 2011;38:419-31.
Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE. Vitiligo Working Group. Current and emerging treatments for vitiligo. J Am Acad Dermatol. 2017 Jul;77(1):17–29.
Whitton M, Pinart M, Batchelor J.M, Leonardi J, Gonzalez U, Jiyad Z. Evidance based management of vitiligo:summary of a cochrane systematic review. Br. J. Dermatol. 174 (5):962-69
Zhu Y, Wang S, Xu A. A mouse model of vitiligo induced by monobenzone. Exp. Dermatol. 2021(7).499-501.
Yaobin P, Shi w, Yingjie H, Qing N, Jing L, Yejing Y, et al. Plant-derived compounds as promising Therapeutics for vitiligo. Frontiers in Pharmacology.2021.
Riding L,RichardM, Harris J. Mouse Model for Human Vitiligo. Curr. protoc. Immunol. 2019 Feb;124(1)
Reddy J, Ranganathan, Jeldi H. A study of phytochemical analysis and antioxidant potentials of use in the treatment of vitiligo. European Journal of Biomedical and pharmaceutical sciences. 2014 Dec;1:471-9
Zhu Y, Zhong L, Peng J, Yuan Q, Xu A. The therapeutic effect baicalin on vitiligo mice. Biol Pharma.Bull. 2019 Sep 1;42(9):1450-5
Huo S.X, Wang Q. The Effect of Butin on the Vitiligo Mouse Model Induced by Hydroquinone. Phytother. Res. 2017;31 (5): 740–6.
Kowichi J, Hiroko, Madhu A, Pathak, Thomas B. Fitzpatrick. Mechanism of depigmentation by Hydroquinone. Journal of Investigative Dermatology.1974; 62(4):436-449
Sun B, Lili W, You W, Chengfei, Lingling Q, Misa H et al. Therapeutic Potential of Centella asiatoca and its Triterpenes : A Review. Frontier in Pharmacology.2020.
Committee on Herbal Medicinal Product. Asessment report on centella asiatica (L.) Urban, herba. 44European Medicines Agency.2010.p:1-44
Lee, T. H., Seo, J. O., Baek, S. H., Kim, S. Y. Inhibitory effects of resveratrol on melanin synthesis in ultraviolet B-induced pigmentation in guinea pig skin. Biomolecules and Therapeutics, 2014.22(1), pp. 35–40.
Oyenihi P, Chegu NN, Oguntibeju, Masola B. Centella asiatica enhances hepatic antioxidant status and regulates hepatic inflammatory cytokines in type 2 diabetic rats. Pharm Biol. 2017 Dec:55 (1):1671-1678
Marasri J, Sunisa S. Development of herbal juice from centella asiatica : antioxidant property and nutritional. Food science and technology.2022
